Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Royala Babayeva

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|March 26, 2022
A boy with a novel homozygous ZAP70 mutation presenting with a dermatological phenotype and postnatal decrease in CD8<sup>+</sup> T cellsRoyala Babayeva, Cedric Mongellaz, Ibrahim Serhat Karakus, et al.
Turkish Archives of Pediatrics|January 13, 2025
Beyond Dermatological Findings: Multisystem Involvement in Prolidase DeficiencyEzgi Yalcin Gungoren, Zeynep Meric, Asena Pinar Sefer, et al.
Journal of Human Immunity|June 11, 2026
A homozygous CTLA-4 variant causes CTLA-4 deficiency with severe immune dysregulationMehmet Cihangir Catak, Salim Can, Satanay Hubrack, et al.
Journal of Clinical Immunology|April 22, 2022
Clinical and Laboratory Factors Affecting the Prognosis of Severe Combined ImmunodeficiencyElif Ozturk, Mehmet Cihangir Catak, Ayca Kiykim, et al.
Journal of Clinical Immunology|March 11, 2023
Correction to: Clinical and Laboratory Factors Affecting the Prognosis of Severe Combined ImmunodeficiencyElif Ozturk, Mehmet Cihangir Catak, Ayca Kiykim, et al.
Journal of Clinical Immunology|April 5, 2024
Rapamycin Controls Lymphoproliferation and Reverses T-Cell Responses in a Patient with a Novel STIM1 Loss-of-Function DeletionIbrahim Serhat Karakus, Mehmet Cihangir Catak, Alexandra Frohne, et al.
The Journal of Allergy and Clinical Immunology|February 9, 2023
Severe allergic dysregulation due to a gain of function mutation in the transcription factor STAT6Safa Baris, Mehdi Benamar, Qian Chen, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 28, 2025
Clinical and Immunological Prognostic Factors With Novel Variants in a Large Cohort of Diacylglycerol Acyltransferase 1 DeficiencyMelek Yorgun Altunbas, Hubert Kogler, Hassan Abolhassani, et al.
The Journal of Allergy and Clinical Immunology|December 4, 2024
Ruxolitinib treatment ameliorates clinical, immunologic, and transcriptomic aberrations in patients with STAT3 gain-of-function diseaseFeyza Bayram Catak, Mehmet Cihangir Catak, Royala Babayeva, et al.
Journal of Clinical Immunology|March 6, 2026
The Experience of a Tertiary Reference Center in Central Anatolia with Children Carrying ZAP-70 Variants, Including Two Novel VariantsSerdar Göktaş, Ozlem Kalaycik Sengul, Şerife Erdem, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|March 26, 2022
A boy with a novel homozygous ZAP70 mutation presenting with a dermatological phenotype and postnatal decrease in CD8<sup>+</sup> T cellsRoyala Babayeva, Cedric Mongellaz, Ibrahim Serhat Karakus, et al.
Turkish Archives of Pediatrics|January 13, 2025
Beyond Dermatological Findings: Multisystem Involvement in Prolidase DeficiencyEzgi Yalcin Gungoren, Zeynep Meric, Asena Pinar Sefer, et al.
Journal of Human Immunity|June 11, 2026
A homozygous CTLA-4 variant causes CTLA-4 deficiency with severe immune dysregulationMehmet Cihangir Catak, Salim Can, Satanay Hubrack, et al.
Journal of Clinical Immunology|April 22, 2022
Clinical and Laboratory Factors Affecting the Prognosis of Severe Combined ImmunodeficiencyElif Ozturk, Mehmet Cihangir Catak, Ayca Kiykim, et al.
Journal of Clinical Immunology|March 11, 2023
Correction to: Clinical and Laboratory Factors Affecting the Prognosis of Severe Combined ImmunodeficiencyElif Ozturk, Mehmet Cihangir Catak, Ayca Kiykim, et al.
Journal of Clinical Immunology|April 5, 2024
Rapamycin Controls Lymphoproliferation and Reverses T-Cell Responses in a Patient with a Novel STIM1 Loss-of-Function DeletionIbrahim Serhat Karakus, Mehmet Cihangir Catak, Alexandra Frohne, et al.
The Journal of Allergy and Clinical Immunology|February 9, 2023
Severe allergic dysregulation due to a gain of function mutation in the transcription factor STAT6Safa Baris, Mehdi Benamar, Qian Chen, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 28, 2025
Clinical and Immunological Prognostic Factors With Novel Variants in a Large Cohort of Diacylglycerol Acyltransferase 1 DeficiencyMelek Yorgun Altunbas, Hubert Kogler, Hassan Abolhassani, et al.
The Journal of Allergy and Clinical Immunology|December 4, 2024
Ruxolitinib treatment ameliorates clinical, immunologic, and transcriptomic aberrations in patients with STAT3 gain-of-function diseaseFeyza Bayram Catak, Mehmet Cihangir Catak, Royala Babayeva, et al.
Journal of Clinical Immunology|March 6, 2026
The Experience of a Tertiary Reference Center in Central Anatolia with Children Carrying ZAP-70 Variants, Including Two Novel VariantsSerdar Göktaş, Ozlem Kalaycik Sengul, Şerife Erdem, et al.
Pageof 2